Central Coast Cancer Center is playing a leading role in the groundbreaking AI liver cancer clinical trial
By NSW Government Publication Date: 2026-06-01 00:00:00 The Gosford-based center is the lead liver cancer site in the trial, which…
Tag: Liver
AI boosts liver cancer detection by highlighting doubtful areas
A new editorial was published in Oncotarget, Volume 16, on April 4, 2025, titled “Deep learning-based uncertainty quantification for quality assurance in…
EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples | European Medicines Agency (EMA)
EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial…
EU health regulator clears use of AI tool in fatty liver disease trials – Reuters
EU health regulator clears use of AI tool in fatty liver disease trials Reuters Article Source https://www.reuters.com/business/healthcare-pharmaceuticals/eu-health-regulator-clears-use-ai-tool-fatty-liver-disease-trials-2025-03-20/